Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
World
Graig Graziosi

A biotech company is beginning trials for a fentanyl vaccine. The CEO says it ‘could completely change’ how overdoses are treated

A biotech company in New York is testing out a fentanyl vaccine that, if effective, could completely upend overdose prevention and treatment.

Fentanyl abuse has been a driving cause of overdoes deaths in the U.S. for more than a decade. According to the Drug Enforcement Administration, fentanyl was responsible for nearly 70 percent of overdose deaths in the U.S. in 2023. In some parts of the country it may be more likely to see a box of overdose-counteracting Narcan on the wall of a public place than a defibrillator.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.